Skip to main content

Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments

Objective

The project entitled: “Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments”, with acronym MEDLEM, has a general objective to foster exchanging knowledge and sharing different culture and approaches in reaching high level of excellence, in research and innovation, in the framework of this field.

The project is aimed at strengthening research collaboration through active networking, staff exchange and dissemination activities between 4 European organizations from Serbia, Germany and France as well as 2 non-European institutions from Thailand and Australia, in linking the fields of microfluidic electronic devices, optimal drug administration, fractional pharmacokinetics, and leukemia treatments. The project will exploit complementary competencies and synergies of the participants, and enable knowledge sharing via international/inter-sectoral mobility, based on secondments of research staff. The consortium offers a unique opportunity that creativity and entrepreneurship will flourish and will help exchanged personnel to turn creative ideas into innovative electronics products, reaching breakthroughs in modelling, drug administration and improvements in therapy protocols.

The main technical goals of the joint research programme are:
- Development of fractional pharmacokinetic models and procedures for parameter identification within these models;
- Design and fabrication of microfluidic device with in-built electronics for optimal drug delivery protocol;
- Pharmacokinetics determination of the pharmaceuticals for leukemia treatments and its testing in vitro and in vivo systems;
- Optimal control problem, its numerical solution and implementation.

The proposal will develop new research links and strengthen the current research links among the partners and will help build up long-term, world-class research in more successful leukemia treatments.

Call for proposal

H2020-MSCA-RISE-2015
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

UNIVERZITET U NOVOM SADU
Address
Dr Zorana Dindica 1
21000 Novi Sad
Serbia
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 166 500

Participants (3)

ELVESYS
France
EU contribution
€ 45 000
Address
172 Rue De Charonne B2 2 Eme Etage
75011 Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MARCOTECH OHG MARKETING, CONTROLLING AND TECHNOLOGY MANAGEMENT
Germany
EU contribution
€ 40 500
Address
Heisenbergstrasse 11
48149 Muenster
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GENOCHEM
France
EU contribution
€ 31 500
Address
34 Traverse De La Paoute
06130 Grasse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (2)

PRINCE OF SONGKLA UNIVERSITY
Thailand
Address
Kanjanawanich Road 15
90110 Hatyai
Activity type
Higher or Secondary Education Establishments
CURTIN UNIVERSITY OF TECHNOLOGY
Australia
Address
Gpo Box U1987
6845 Perth
Activity type
Higher or Secondary Education Establishments